您的位置: 首页 > 农业专利 > 详情页

PROVISION OF NEW CARDIOMYOCYTE PROGENITOR CELLS AND CARDIOMYOCYTES DERIVED THEREFROM
专利权人:
LEAD PHARMA CEL MODELS IP B.V.
发明人:
GOUMANS, MARIE, JOSE,DOEVENDANS, PIETER
申请号:
NZ57872808
公开号:
NZ578728A
申请日:
2008.01.09
申请国别(地区):
NZ
年份:
2012
代理人:
摘要:
Disclosed are human cardiomyocyte progenitor cells (CMPCs) from human heart tissue that are characterised by the Sca-1 or Sca-1 eptiope and CD31 on the cell surface. Further disclosed are methods for ex vivo isolation of CMPCs and differentiation of CMPCs into mature cardiomyocytes using a demethylating agent (5-azacytidine or 5-aza-2-deoxycytidine) and TGF-beta. Further disclosed are pharmaceutical compositions comprising cardiomyocytes for use in cardiomyocyte replacement therapy and for the treatment of myocardial infarction or for ameliorating the effects of myocardial infarction.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充